step semaglutide FDA has approved a new, higher-dose 7.2 mg weekly injection of #Wegovy (# semaglutide) for long-term weight management in adults with obesity or overweight. 🔹Indication: It is intended as a “step-up” therapy for STEP 1 : Semaglutide Treatment

Their active ingredient, semaglutide, belongs to a class of GLP-1 receptor agonists that work to reduce weight by mimicking a naturally occurring hormone that signals your body to feel full and slows digestion by increasing the time it takes for food to leave the body

[DOI] [PubMed] [Google Scholar] Schinner S, Barthel A, Dellas C, Grzeskowiak R, Sharma SK, Oetjen E, Blume R, Knepel W

So, for example, if your current tirzepatide injection day is Sunday afternoon and : You want to change it to Monday, youll skip that Sunday and take it on Monday moving forward

Yamada Y et al

While human studies are still limited, the potential of GLP-1 medications to address the neurobiological underpinnings of addiction holds promise for developing novel pharmacological interventions and improving addiction treatment outcomes

They have been effective in helping to reduce HbA1c levels, which is a measure of blood sugar control over time